Can immunohistology improve detection of lymph-node metastases in large-bowel cancer?
- 1 February 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 32 (2) , 99-102
- https://doi.org/10.1007/bf02553819
Abstract
Employing the monoclonal antibody CAM5.2, the sensitivity of immunohistologic staining was compared with conventional hematoxylin and eosin staining for detection of lymph-node metastases from large-bowel cancer. Ten patients who died unexpectedly early from recurrent disease were selected; 86 lymph nodes were examined. Where metastases were located they were readily identified by both methods but when the original lymph-node sections were reviewed, attention was drawn to two metastatic deposits that had been overlooked previously. These results suggest that immunohistologic techniques offer no advantage in the identification of lymph-node metastases in largebowel cancer.Keywords
This publication has 9 references indexed in Scilit:
- Monoclonal antibody to cytokeratin for use in routine histopathology.Journal of Clinical Pathology, 1984
- DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCERThe Lancet, 1983
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982
- Histopathology reporting in large bowel cancer.Journal of Clinical Pathology, 1981
- The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sectionsBritish Journal of Cancer, 1980
- The clinical significance of invasion of veins by rectal cancerBritish Journal of Surgery, 1980
- New Human Tumor Cell LinesPublished by Springer Nature ,1975
- The Spread of Rectal Cancer and its Effect on PrognosisBritish Journal of Cancer, 1958
- The classification of cancer of the rectumThe Journal of Pathology and Bacteriology, 1932